Search

Un ensayo clínico de MSK está ayudando a Gail Goode a superar el mieloma múltiple y arroja nueva luz sobre cómo el cáncer afecta a personas de diversos orígenes étnicos.

… Tuesday, September 3, 2024 Existe una necesidad urgente de reclutar a pacientes más diversos en los ensayos clínicos de cáncer . Una de las razones por las que es tan importante es que los investigadores están descubriendo que ciertos tipos de cáncer ocurren con mayor frecuencia en personas de determinadas

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.

… Monday, November 25, 2013 Summary Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering. Renowned cancer biologist Joan Massagué has been named

Experts from MSK shared their work in more than 40 presentations and poster sessions at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology.

… Wednesday, October 4, 2023 Researchers from Memorial Sloan Kettering Cancer Center (MSK) were recognized for their achievements at the 2023 meeting of ASTRO, the American Society for Therapeutic Radiology and Oncology. Teams reported new findings about radiation-induced secondary cancers, a new guidance

Find out when to consult a doctor for a bad headache.

… Monday, June 20, 2022 Summary MSK neuro-oncologist Lauren Schaff discusses when to see a doctor for a headache. Updated June 20, 2022 A bad headache can be a frightening experience. But sometimes, even scarier than the pounding in your head can be the tricks your mind plays on you as it’s happening.

The American Heart Association recently issued a statement about the risk of cardiovascular disease for women with breast cancer.

… Thursday, February 1, 2018 Summary The medications that some women take for breast cancer treatment may cause heart problems. Here, we break down what these women should know. The American Heart Association recently issued a statement about the dangers of heart problems in women treated for breast cancer

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.

… Wednesday, May 18, 2022 New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach on 114 pediatric, adolescent, and young adult patients with solid tumors. The

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.

… Friday, September 28, 2018 Summary Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA for the treatment of patients with high-risk neuroblastoma. Neuroblastoma is a rare cancer of the nerve tissue that usually arises in the abdomen. It mainly affects young children

Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.

… Wednesday, May 30, 2012 Summary Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States. Two Memorial Sloan Kettering investigators have been named members of the National Academy

… Monday, May 5, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Jennifer Oakvik and Adrienne Bloom Recognized by the Oncology Nursing Society Awards Jennifer Oakvik, MSN, RN, CMSRN, nurse leader,  received the Emerging Leader Award from the Oncology

The watch and wait approach to treatment, also called active surveillance, is common for lymphomas that pose no immediate threat to a patient’s health. But the tactic can leave some patients initially feeling anxious.

… Friday, April 8, 2016 Summary The watch and wait approach to treatment, also called active surveillance, is common treatment for lymphomas that pose no immediate threat to a patient’s health. This hands-off method has been proven to work just as well as active treatment in select patients, and negates